Gene · 6839
NIH grants2,112
NIH grants whose papers are about the gene, through NIH's grant-paper links.
281 to 300 of 2,112
Download this page as JSON| Grant | Title | SUV39H1 papers | Newest fiscal year |
|---|---|---|---|
| R35GM139816 | Novel pathways that regulate DNA double-strand break repair events in mammalian cells | 1 | 2025 |
| R35GM140929 | Acoustothermogenetics for Cell Engineering | 1 | 2025 |
| R35GM141805 | Mechanistic insight into genome stability pathways | 1 | 2025 |
| R35GM141888 | Tracking how molecular machines propagate epigenetic information in time and space | 1 | 2025 |
| R35GM142837 | Probing the Formation and Function of Transcription Hubs | 1 | 2025 |
| R35GM144307 | DNA Replication Checkpoint in Fission Yeast | 1 | 2025 |
| R35GM154928 | Role of chromatin mechanics in nuclear shape and integrity | 1 | 2025 |
| R37CA238274 | Restoring Progestin Sensitivity in Endometrial Cancer | 1 | 2025 |
| R37CA240625 | Investigating p16 Loss in Pro-tumorigenic Metabolism | 1 | 2025 |
| R37CA241486 | Molecular mechanisms underlying lineage plasticity in prostate cancer | 1 | 2025 |
| R37CA251270 | Regulation of repetitive elements in cancer by P53 and epigenetic mechanisms | 1 | 2025 |
| R50CA211199 | Integrative Approach to Comprehensive Analysis of High Throughput Data on a Cancer Center Level | 1 | 2025 |
| R50CA211397 | Functional Analysis of Structure Specific Nucleases in Genome Stability and Cancers | 1 | 2025 |
| R50CA265307 | Targeting EGFR mutant tyrosine kinase inhibitors (TKIs) resistant and drug-tolerant persister cells in non-small cell lung cancer (NSCLC) | 1 | 2025 |
| RM1HG008935 | Center for dynamic RNA epitranscriptomes - Renewal | 1 | 2025 |
| RM1HG009490 | Center for Genomic Editing and Recording: Development and Application of Next-Generation Genome and Epigenome Editing Methods to Advance the Study and Treatment of Human Disease | 1 | 2025 |
| T32AG000279 | Integrative Physiology of Aging Training Grant | 1 | 2025 |
| T32AG041688 | Brown University Training Program in the Molecular Biology of Aging | 1 | 2025 |
| T32AI007110 | Basic Microbiology and Infectious Disease | 1 | 2025 |
| T32AI007533 | Training in Molecular Virology, Viral Pathogenesis and Viral Vectors | 1 | 2025 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6839/grants?page=15